Apricus Biosciences Balance Sheet - Quarterly (NASDAQ:APRI)

Add to My Stocks
$0.28 $0 (0%) APRI stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Apricus Biosciences stock analysis. As in our Apricus Biosciences stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Apricus Biosciences revenue Apricus Biosciences operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Apricus Biosciences balance sheet for 2018 Q2 shows cash on hand of $6.84M. The company has a debt to equity ratio of 0.

View and download Apricus Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets-----1.38M----
Total Current Assets
Property Plant & Equipment------1.82M---
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable--6.65M9.47M-2.6M-4M-12.12M
Accounts Payable1.05M------1.43M1.6M1.09M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses-1.34M1.51M1.45M1.37M1.28M3.68M3.8M3.34M3.3M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities-----1.85M-3.34M2.34M4.02M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus325.8M322.53M320.34M319.84M316.26M309.06M308.78M308.46M305.21M304.47M
Retained Earnings-320.54M-318.25M-315.98M-313.54M-309.7M-308.23M-316.3M-316M-314.71M-311.38M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity5.28M4.28M4.37M6.31M6.57M--7.51M-7.53M-9.44M-6.84M
Total Liabilities & Shareholders Equity7.22M6.02M6.7M8.82M8.81M5.35M4.7M8.41M6.16M10.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Apricus Biosciences historical stock prices and the current Apricus Biosciences stock price can tell you how the stock price has moved, whereas the Apricus Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Apricus Biosciences owns and has monetary significance. APRI assets grew from $6.02M in 2018 Q1 to $7.22M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Apricus Biosciences is $1.94M. Shareholders equity comes under liabilities as it is money the company owes the holders of APRI stock.

Apricus Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover